Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
The government wants to buy their flood
Xinhua Headlines: Xi, Lula Map out Future China
Xi Focus: Xi Stresses Deepening Reform, Expanding Opening up, Advancing Chinese Modernization
Fishermen harvest sea cucumbers in NE China
Sweden beats France, Britain relegated after losing to Norway at hockey worlds
Scenery of Minjiang River estuary wetland in Fuzhou
In pics: natural landscapes in Africa
African lion cubs survive extreme environment of Qinghai
A warrant for Netanyahu’s arrest was requested. But no decision was made about whether to issue it
Jiangcun Village in East China's Jiangsu: sample of China's rural development
Red Lobster seeks bankruptcy protection after closing some restaurants
People go outside to enjoy scenery of flowers in many parts of China